BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19620289)

  • 41. CBFβ-MYH11 interferes with megakaryocyte differentiation via modulating a gene program that includes GATA2 and KLF1.
    Yi G; Mandoli A; Jussen L; Tijchon E; van Bergen MGJM; Cordonnier G; Hansen M; Kim B; Nguyen LN; Jansen PWTC; Vermeulen M; van der Reijden B; van den Akker E; Bond J; Martens JHA
    Blood Cancer J; 2019 Mar; 9(3):33. PubMed ID: 30850577
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression.
    Zini R; Norfo R; Ferrari F; Bianchi E; Salati S; Pennucci V; Sacchi G; Carboni C; Ceccherelli GB; Tagliafico E; Ferrari S; Manfredini R;
    Exp Hematol; 2012 Dec; 40(12):1043-1054.e6. PubMed ID: 22885124
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The expression pattern of erythrocyte/megakaryocyte-related transcription factors GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia.
    Shimamoto T; Ohyashiki K; Ohyashiki JH; Kawakubo K; Fujimura T; Iwama H; Nakazawa S; Toyama K
    Blood; 1995 Oct; 86(8):3173-80. PubMed ID: 7579412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The biologic properties of recombinant human thrombopoietin in the proliferation and megakaryocytic differentiation of acute myeloblastic leukemia cells.
    Matsumura I; Kanakura Y; Kato T; Ikeda H; Horikawa Y; Ishikawa J; Kitayama H; Nishiura T; Tomiyama Y; Miyazaki H; Matsuzawa Y
    Blood; 1996 Oct; 88(8):3074-82. PubMed ID: 8874206
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1.
    Zhang P; Behre G; Pan J; Iwama A; Wara-Aswapati N; Radomska HS; Auron PE; Tenen DG; Sun Z
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8705-10. PubMed ID: 10411939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. GATA transcription factors inhibit cytokine-dependent growth and survival of a hematopoietic cell line through the inhibition of STAT3 activity.
    Ezoe S; Matsumura I; Gale K; Satoh Y; Ishikawa J; Mizuki M; Takahashi S; Minegishi N; Nakajima K; Yamamoto M; Enver T; Kanakura Y
    J Biol Chem; 2005 Apr; 280(13):13163-70. PubMed ID: 15673499
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differentiation of murine committed megakaryocytic progenitors isolated by a novel strategy reveals the complexity of GATA and Ets factor involvement in megakaryocytopoiesis and an unexpected potential role for GATA-6.
    Dumon S; Heath VL; Tomlinson MG; Göttgens B; Frampton J
    Exp Hematol; 2006 May; 34(5):654-63. PubMed ID: 16647571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ets-dependent regulation of target gene expression during megakaryopoiesis.
    Jackers P; Szalai G; Moussa O; Watson DK
    J Biol Chem; 2004 Dec; 279(50):52183-90. PubMed ID: 15466856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pluripotent stem cell model of early hematopoiesis in Down syndrome reveals quantitative effects of short-form GATA1 protein on lineage specification.
    Matsuo S; Nishinaka-Arai Y; Kazuki Y; Oshimura M; Nakahata T; Niwa A; Saito MK
    PLoS One; 2021; 16(3):e0247595. PubMed ID: 33780474
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integrating Enhancer Mechanisms to Establish a Hierarchical Blood Development Program.
    Mehta C; Johnson KD; Gao X; Ong IM; Katsumura KR; McIver SC; Ranheim EA; Bresnick EH
    Cell Rep; 2017 Sep; 20(12):2966-2979. PubMed ID: 28930689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy.
    Fujiwara T; O'Geen H; Keles S; Blahnik K; Linnemann AK; Kang YA; Choi K; Farnham PJ; Bresnick EH
    Mol Cell; 2009 Nov; 36(4):667-81. PubMed ID: 19941826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A role of jumonji gene in proliferation but not differentiation of megakaryocyte lineage cells.
    Kitajima K; Kojima M; Kondo S; Takeuchi T
    Exp Hematol; 2001 Apr; 29(4):507-14. PubMed ID: 11301191
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of transcription factors during megakaryocytic differentiation of CD34+ cells from human cord blood induced by thrombopoietin.
    Terui K; Takahashi Y; Kitazawa J; Toki T; Yokoyama M; Ito E
    Tohoku J Exp Med; 2000 Dec; 192(4):259-73. PubMed ID: 11286316
    [TBL] [Abstract][Full Text] [Related]  

  • 54. STAT1 promotes megakaryopoiesis downstream of GATA-1 in mice.
    Huang Z; Richmond TD; Muntean AG; Barber DL; Weiss MJ; Crispino JD
    J Clin Invest; 2007 Dec; 117(12):3890-9. PubMed ID: 18060035
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histone demethylase LSD1-mediated repression of GATA-2 is critical for erythroid differentiation.
    Guo Y; Fu X; Jin Y; Sun J; Liu Y; Huo B; Li X; Hu X
    Drug Des Devel Ther; 2015; 9():3153-62. PubMed ID: 26124638
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcriptional regulation by GATA1 and GATA2 during erythropoiesis.
    Suzuki M; Shimizu R; Yamamoto M
    Int J Hematol; 2011 Feb; 93(2):150-155. PubMed ID: 21279818
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Megakaryocytic differentiation induced in 416B myeloid cells by GATA-2 and GATA-3 transgenes or 5-azacytidine is tightly coupled to GATA-1 expression.
    Visvader J; Adams JM
    Blood; 1993 Sep; 82(5):1493-501. PubMed ID: 7689871
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Defects of the heart, eye, and megakaryocytes in peroxisome proliferator activator receptor-binding protein (PBP) null embryos implicate GATA family of transcription factors.
    Crawford SE; Qi C; Misra P; Stellmach V; Rao MS; Engel JD; Zhu Y; Reddy JK
    J Biol Chem; 2002 Feb; 277(5):3585-92. PubMed ID: 11724781
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Critical Roles for PU.1, GATA1, and GATA2 in the expression of human FcεRI on mast cells: PU.1 and GATA1 transactivate FCER1A, and GATA2 transactivates FCER1A and MS4A2.
    Inage E; Kasakura K; Yashiro T; Suzuki R; Baba Y; Nakano N; Hara M; Tanabe A; Oboki K; Matsumoto K; Saito H; Niyonsaba F; Ohtsuka Y; Ogawa H; Okumura K; Shimizu T; Nishiyama C
    J Immunol; 2014 Apr; 192(8):3936-46. PubMed ID: 24639354
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cross-talk of GATA-1 and P-TEFb in megakaryocyte differentiation.
    Elagib KE; Mihaylov IS; Delehanty LL; Bullock GC; Ouma KD; Caronia JF; Gonias SL; Goldfarb AN
    Blood; 2008 Dec; 112(13):4884-94. PubMed ID: 18780834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.